Pulmozyme 1 MG/ML ampul 2.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV261
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,431
Award facts
- Contract value 100% obligated
- $20,430.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,430.93 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 6, 2026, for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml units). This non-competitive delivery order, with an ultimate completion date of January 7, 2026, represents a task order against AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. Pulmozyme is a specialty pharmaceutical used in respiratory care, aligning with the Defense Logistics Agency's broader mission to supply critical medications to military healthcare systems and treatment facilities worldwide.
This delivery order is issued under Cencora, Inc.'s $999.99 billion IDC with the DLA Troop Support Medical, which is valued through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a non-set-aside award, the contract was competitively awarded, demonstrating AmerSourceBergen's established capability to meet federal procurement requirements for essential pharmaceutical commodities. The award reflects the company's significant role in supporting the Defense Health Agency and other federal healthcare systems through flexible, delivery-based contract mechanisms designed to ensure timely access to specialty medications and medical supplies.
Quick answers
Who was awarded contract SPE2DR26FV261?
SPE2DR26FV261 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FV261 worth?
The government has obligated $20,431 on SPE2DR26FV261.
Is contract SPE2DR26FV261 an order under another contract?
Yes. SPE2DR26FV261 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV261 competed?
The extent of competition for SPE2DR26FV261 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award